Indefinite Delivery Contract HHSD200201562101I

The Vaccines for Children (VFC) Indefinite Delivery Contract represents a critical federal procurement vehicle for vaccine supply and distribution to support the Centers for Disease Control and Prevention's VFC program. Awarded to Merck Sharp & Dohme LLC on April 1, 2025, this multiple-award contract carries a ceiling value of $4.38 billion and extends through March 31, 2026. As a civilian-side procurement with no set-aside designation, this IDV was awarded through open and competitive...

Merck Sharp & Dohme LLC has been awarded a Federal Supply Schedule (FSS-61-IB) contract by Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, with a ceiling value of $5.84 billion and a performance period extending through May 31, 2030. This multiple-award indefinite delivery vehicle establishes Merck as a primary source for pharmaceutical products and hematology-related supplies across the Veterans Affairs healthcare system. The contract...

Merck Sharp & Dohme LLC, doing business as Merck, is the prime contractor on a Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs with the U.S. federal government. This IDV contract has a ceiling value of $6,073,473,460.00 and an ultimate completion date of June 1, 2025. Under this contract, Merck has been awarded numerous delivery orders and task orders by civilian federal agencies such as the Department of Veterans Affairs, Centers for Disease Control and...

This indefinite delivery contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) Pittsburgh to procure a variety of pharmaceutical drugs and vaccines. The $5,863,720.17 contract has a period of performance from September 16, 2016 to September 15, 2021. Merck, a major pharmaceutical manufacturer, is providing the CDC with multiple vaccine types for both adult and pediatric populations under this IDV. This includes...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a $2,993,341,000 ceiling value and a period of performance from April 1, 2021 through March 31, 2022. The purpose of this IDC is to provide a range of standard pediatric vaccines required to support immunization...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Merck Sharp & Dohme LLC, doing business as Merck, to provide 2019 Vaccines for Children. The contract has a potential value of $2,495,643,500.00 and a period of performance from April 1, 2019 to March 31, 2020. As a major pharmaceutical manufacturer, Merck will deliver a wide range of pediatric and adult vaccines to fulfill the Vaccines for...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation. The contract has a ceiling value of $1,465,459,641.64 and a period of performance from July 1, 2009 to June 30, 2010. The IDC is focused on providing VFA 2009, which likely refers to vaccine-related products and services. Merck Sharp & Dohme Corp. has been awarded multiple...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center (NAC), a civilian federal agency, to Merck Sharp & Dohme LLC, doing business as Merck, a prominent pharmaceutical manufacturer. The $15,000,000 BPA is for the procurement of the cancer drug Welireg (belzutifan) and does not utilize any set-aside designations, indicating an open and competitive award process. The BPA has an ultimate completion date of July 7, 2025 and was awarded on August 9, 2022. Merck, a...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the purchase of 20 standard pediatric vaccines. The contract supports the CDC's Vaccines for Children program and adult vaccination initiatives under Section 317(j) of the Public Health Service Act. This multiple award IDC has a total ceiling value of $2,565,312,500 and a period of performance of 12 months from the award date...

This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp., a subsidiary of Schering Plough Corporation, to provide vaccine-related services. The single-award contract has a ceiling value of $56,988,922.50 and a period of performance through February 28, 2011. The contract was not set aside and aims to procure vaccine storage and rotation services. This delivery order contract is one of...